U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07482319) titled 'A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors' on March 16.
Brief Summary: An Open-label, Single-arm, Phase I Clinical Study of GK01 Cell Injection in the Treatment of Patients with Advanced Malignant Solid Tumors
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumors
Intervention:
DRUG: GK01 injection
Autologous tumor-reactive T cells injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Beijing Geekgene Technology Co., LTD
Published by HT Digital Content Services with permission from Health Daily Digest....